OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Release Date
2021
(3)
2012
(3)
2024
(2)
2025
(1)
2022
(1)
2020
(1)
2019
(1)
2016
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.
Not available
S-EPMC7924264
|
biostudies-literature
Cite
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response.
Not available
S-EPMC11419200
|
biostudies-literature
Cite
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response.
Not available
S-EPMC12717172
|
biostudies-literature
Cite
Comprehensive genomic characterization of squamous cell lung cancers.
Not available
S-EPMC3466113
|
biostudies-literature
Cite
Comprehensive molecular characterization of clear cell renal cell carcinoma.
Not available
S-EPMC3771322
|
biostudies-literature
Cite
Comprehensive molecular characterization of human colon and rectal cancer.
Not available
S-EPMC3401966
|
biostudies-literature
Cite
De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population.
Not available
S-EPMC7007577
|
biostudies-literature
Cite
Comprehensive molecular portraits of human breast tumours.
Not available
S-EPMC3465532
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
Global variation in anastomosis and end colostomy formation following left-sided colorectal resection.
Not available
S-EPMC6921967
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets